Our team is here to walk you through each step and make sure you feel confident and at ease
On June 24, 2026, Novo Nordisk, a global leader in diabetes and obesity treatments, officially launched its flagship weight-loss drug Wegovy (Semaglutide) in India
As physicians prescribed semaglutide for their patients with type 2 diabetes, they noticed an unexpected side effect significant weight loss
This meant that the legal basis for most compounding of tirzepatide essentially disappeared
At the start of the study, all participants were struggling to manage their diabetes, with an average blood sugar A1C level of 8.3 percent
There are many factors to consider, but it all comes down to how much of the supplement can be absorbed